AbbVie, Voyager Team Up to Develop Antibodies for Parkinson’s, Other Diseases - Parkinson's News Today

AbbVie, Voyager Team Up to Develop Antibodies for Parkinson’s, Other Diseases  Parkinson's News Today

Read about how AbbVie and Voyager Therapeutics have extended their collaboration to co-develop and commercialize antibodies to treat Parkinson's disease.